6-Bromoimidazo[1,2-a]pyridine-3-carboxamide

Introduction

CAS No. :	2044706-79-6	MDL No. :	MFCD30536238
Formula :	C8H6BrN3O	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	BAYFFRVCYNOEHD-UHFFFAOYSA-N
M.W :	240.06	Pubchem ID :	123134782
Synonyms :

Physicochemical Properties

Num. heavy atoms :	13
Num. arom. heavy atoms :	9
Fraction Csp3 :	0.0
Num. rotatable bonds :	1
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	50.99
TPSA :	60.39 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.62
Log Po/w (XLOGP3) :	1.66
Log Po/w (WLOGP) :	1.2
Log Po/w (MLOGP) :	0.65
Log Po/w (SILICOS-IT) :	0.72
Consensus Log Po/w :	1.17

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.82
Solubility :	0.363 mg/ml ; 0.00151 mol/l
Class :	Soluble
Log S (Ali) :	-2.54
Solubility :	0.689 mg/ml ; 0.00287 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-2.53
Solubility :	0.702 mg/ml ; 0.00292 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.82

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P305+P351+P338	UN#:
Hazard Statements:	H302-H315-H319-H335	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine